Managing disclosure of research misconduct by a graduate student to a university mental health professional during a clinical counseling session

Am J Bioeth. 2013;13(10):68. doi: 10.1080/15265161.2013.828534.

Abstract

This case looks at the question of how to consider obligations of confidentiality by a mental health professional who works for an institution and learns that a student has been using a drug intended for an animal research project. Dr. Paul Appelbaum, MD, a psychiatrist at Columbia University, examines the issue of the limits of confidentiality. Nicholas Steneck, PhD, a scholar in research misconduct at the University of Michigan, explores the obligations to report research misconduct. Walter Limehouse, MD, an ethicist at the Medical University of South Carolina, considers the systems issues raised by this case and offers some suggestions that might change the institutional environment.

MeSH terms

  • Animal Experimentation / ethics*
  • Confidentiality / ethics*
  • Controlled Substances
  • Counseling
  • Disclosure / ethics*
  • Drugs, Investigational*
  • Ethics Consultation
  • Humans
  • Mental Health
  • Professional-Patient Relations / ethics*
  • Scientific Misconduct*
  • Students*
  • Substance-Related Disorders*
  • Theft
  • United States
  • Universities

Substances

  • Controlled Substances
  • Drugs, Investigational